A
e prevalence of heaves has been reported to vary between 3-20% [1] [2] [3] . Heaves is an asthma-like disease of horses that typically manifests with clinical signs such as increased respiratory rate and e ort, productive cough, and exercise intolerance. is reaction appears to be an allergic response to the molds and dusts present in the hay, straw, and barn environment, and results from prolonged exposure to environments that contain high amount of aeroallergens [4] . A genetic predisposition for heaves is supported by several reports. In one report, the prevalence of heaves in two populations of Swiss warmblood horses was higher in o springs from two heaves-a ected stallions compared to control populations from non-heaves-a ected stallions. 5 In this population of horses, an association was found between clinical signs of heaves and microsatellite markers near the gene for the IL-4 receptor in the descendants of one heavesa ected Swiss warmblood stallion, but not the second stallion, suggesting that this is a multifactorial, perhaps polygenic, disease [5] .
Since heaves is triggered by exposure to inhaled allergens, the analysis of bronchoalveolar lavage uid (BALF) would seem to be the most likely uid to yield potential biomarkers for disease. However, over 500 proteins have been identi ed in equine BALF making detection of di erential protein expression using traditional methods (e.g. ELISA, Western blot) a daunting task [6] . In order to evaluate a larger number of proteins at once, we used proteomic techniques during the discovery phase of this experiment. Proteomics uses large-scale protein expression technologies for the identi cation and quanti cation of proteins that might be altered in response to various insults or diseases [7] . As a result, proteomics can be very valuable to investigate the pathophysiology of complex diseases.
Although the proteome of equine BALF has previously been reported in healthy horses [6] , BALF proteome changes in heaves have not been reported. Our hypothesis was that the BALF of heaves-a ected horses would show di erential protein expression, compared to the BALF of healthy horses. We chose to use LC-MS and LC-MS/MS protocols as this approach allows for global evaluation of average relative peptide concentrations between groups of horses in the rst step of analysis (LC-MS) and identi cation of highly expressed peptides in the second step of analysis (LC-MS/MS) [8, 9] . Finally, we used Western blot techniques to con rm the identity and expression pattern of two proteins identi ed with proteomic techniques.
Material and Methods
Animals. Horses with heaves (n = 8) were selected from a herd of horses owned by Purdue University College of Veterinary Medicine (PUCVM). ese horses had been previously diagnosed with heaves based on maximum change in transpulmonary pressure (ΔP Lmax ) ≥ 15 cmH 2 O, reversible airway obstruction, and ≥ 25% neutrophils in BALF cytology during disease exacerbation [10] . Control horses (n = 8) were recruited from the PUCVM teaching herd. e control horses were judged to be normal based on physical examination and no history of clinical signs attributable to chronic respiratory disease when fed hay and housed indoors. e heaves-a ected horses were 4 females and 4 castrated males; 5 Quarter Horse-type breeds, 1 walking horse, 1 Arabian cross, and 1 Icelandic pony. e control horses were 7 females and 1 castrated male; 3 standardbreds, 2 Quarter Horse-type breeds, 1 thoroughbred, 1 walking horse, and 1 Arabian. e Purdue University Animal Care and Use Committee approved all procedures.
All horses were maintained on pasture for at least two months before the beginning of this study. On Day 1, all horses were transported from the pasture to the laboratory and allowed at least 30 minutes of acclimatization. e evaluation included a complete physical examination, standard pulmonary function testing (PFT), and BAL. A er the horses recovered from sedation, they were returned to the pasture for one week. is testing was repeated three times over two weeks to assess the stability of the measurements over time. A er the third test, each pair of horses (one heavesa ected and one control) was stalled in a barn in adjacent stalls for a hay exposure trial.
Experimental Exposure. All horses were fed moldy hay (0.2 kg/45 kg body weight) mixed with good quality hay (0.5 kg/45 kg body weight) and pelleted feed a (0.3 kg/45 kg body weight), and were bedded on straw. A physical examination was performed and a clinical score based on severity of clinical signs was calculated daily on each horse. e clinical score is based on the respiratory rate and e ort, presence of abnormal lung sounds, and degree of nasal discharge [11] . Horses were exposed to hay for up to 21 days, or until the clinical score of the heaves-a ected horse reached 10 (out of 21 possible). When the heaves-a ected horse had a clinical score of ≥ 10, PFT was performed; when the heaves-a ected horse had a ΔP Lmax ≥ 15 cmH 2 O, the tests performed at baseline were repeated on the heaves-a ected horse and its control.
Pulmonary Function Evaluation. Testing was performed according to standard laboratory procedure, as previously described [12] . Horses were restrained in stocks without sedation to allow breath-by-breath measurement of esophageal and mask pressures as well as air ow. Data analysis of ten representative breaths yielded total pulmonary resistance, dynamic compliance, and ΔP Lmax . A er completion of the PFT, horses were sedated with detomidine b (0.03 mg/kg) and butorphanol c (0.02 mg/kg) and BAL was performed as previously reported, using a exible 2-meter videoendoscope [12] . d Two di erent segments of the same lung were infused with 250 mL sterile saline per site. e aspirated BALF was pooled, immediately placed on ice, and processed within 20 minutes of collection. An aliquot was prepared for cytological examination by 1. Introduction cytocentrifugation and stained with modi ed Wright's stain. Total nucleated cell counts were determined by use of a hemacytometer. Di erential cell counts were determined by examination of 200 leukocytes per slide.
e clinical pathologist evaluating the BALF cytology was blinded to each horse's group identity.
Sample Preparation for Proteomics Analysis. e BALF was prepared for proteomic analysis according to standard laboratory procedures (details provided in Additional File 1). Brie y, the BALF was ltered through sterile gauze and centrifuged. Protein concentration of the supernatant was determined with a BCA Assay e and a volume equivalent to 100 µg of protein from each BALF sample was incubated with cold acetone at -20 o C to precipitate proteins. e precipitate was lyophilized and digested with trypsin. Samples were processed in batches, and the peptide solutions were stored at -20 o C until mass spectrometric analysis.
LC-MS Analysis. In this study, a two-step proteomic approach was used. In the rst step, all available postexposure samples (heaves-a ected n = 5, control n = 6) were analyzed by a simple LC-MS technique for quantitative purposes.
is data was used to generate the average relative peptide concentrations within each group of horses (heavesa ected and controls), and to determine the fold change between the two groups. In second step we performed MS/MS analysis on BALF samples from one heaves-a ected and one control horse.
Peptides from each BALF sample at the exposure testing period (control n = 6; heaves-a ected n = 5; 1 µg of peptides from each sample) were subjected to LC-MS analysis on a nanoLC-Chip system, f according to standard laboratory protocol (details in Additional File 1). Bu er A (5% ACN/0.01% TFA) was used to concentrate the peptides on the on-chip enrichment column and to separate the peptides on the reversed phase analytical column. e column was eluted with a 55 minute gradient from 5%-35% bu er B (100% ACN/0.01% TFA), followed by a 10 minute gradient from 35%-100% bu er B.
e column was re-equilibrated between each sample with isocratic ow of 5% bu er B. e system was controlled by ChemStation so ware. g Data generated with LC-MS were analyzed with the Purdue Discovery Pipeline h (PDP). Average relative concentrations of each peak in the groups (heaves-a ected and controls) and the relative fold change for each peak between groups were determined [13] . e raw data from the LC-MS were pre-processed before analysis to eliminate artifacts such as noise, peak broadening, instrument distortion, etc [13] . e mean intensity of each peak was calculated for each group (heaves-a ected n = 5 and control n = 6) and the fold change of each peptide between groups was calculated. When a peptide was absent in a group of horses, a placeholder value of "10" was used to facilitate statistical analysis. A peak had to be found in at least 7 of 11 BALF samples or in at least 1 of the BALF samples from one group (heavesa ected or control) to be considered in the analysis.
LC-MS/MS Analysis. In a separate experiment, BALF samples from one heaves-a ected and one control horse from the exposure testing period were subjected to LC-MS/ MS (tandem MS) analysis on the same nanoLC-chip system f according to standard laboratory procedure (details in Additional File 1). Assuming each peptide is present in every heaves-a ected and control horse, analyzing a single sample should be su cient for identi cation purposes. But because not every peptide was present in both groups of horses, we chose a single representative sample from each group for LC -MS/MS analysis based on the LC-MS peak list of those samples to ensure that 1) most of the signi cantly di erent peptide peaks were detected in that sample, and 2) the peptide peak of the regulated peptides were intense peaks. Automated MS/MS spectra were acquired during each run in the data-dependent acquisition mode, with the selection of the three most abundant precursor ions in each peak. Analysis of the data generated during tandem MS runs yielded identications of the parent proteins of the peptides detected (see Peak Identi cation, below).
Peak Identi cation. Files acquired during the tandem MS runs were uploaded to Spectrum Mill protein identi cation so ware. g Two databases were downloaded from NCBI i in 2009, the non-redundant equine protein database (downloaded 2/24/09; 29,374 proteins) and the nonredundant mammalian database (downloaded 1/26/09; 7,745,744 proteins). Identi cation of the peptides was performed using Spectrum Mill to separately search the two NCBI protein databases.
e search parameters were: no more than two tryptic miscleavages allowed, cysteine searched as ethanol cysteine, variable oxidized methionine, 2.5 Da peptide tolerance, and 0.7 Da mass tolerance. Only peptides with a score of 5 or higher were considered true positives. e identi cation data from Spectrum Mill analysis was matched with the concentration data from PDP analysis by merging the output les from the two data analyses for each horse into one le. A list of peptide identi cations, with associated relative concentrations, was made for as many peaks as possible, based on m/z, retention time, and peptide charge. Please see Additional File 1 for more details.
Western blot. Western blots were performed according to the manufacturer's recommendations j on all baseline and exposure BALF samples (controls n = 8 for baselines 1, 2, 3 and exposure; heaves-a ected n = 5 for baselines 1, 2, exposure and n = 4 for baseline 3) with 2 µg of protein from each sample. Ten BALF samples were concentrated to achieve a protein concentration of approximately 0.2-0.3 μg/μL. k ImageJ so ware i was used to quantify the density of the bands from the protein of interest on each Western blot. (Details in Additional File 1)
Secretoglobin. In order to validate the identi cation of secretoglobin from the proteomics data, Western blot was performed on all baseline and exposure BALF samples. Two μg of protein from each sample was prepared as described above. e positive control protein was equine recombinant secretoglobin. l e primary antibody was monoclonal rabbit anti-horse secretoglobin antiserum [14] l , at a dilution of 1:1000. e secondary antibody was horseradish peroxidaseconjugated goat anti-rabbit IgG, m at a dilution of 1:2000.
Transferrin. In order to validate the identi cation of transferrin from the proteomics data, Western blot was performed on all baseline and exposure BALF samples. Two μg of protein from each sample was prepared as described above. e positive control protein was human apo-transferrin. n e primary antibody was polyclonal sheep anti-horse transferrin, o at a dilution of 1:10,000. According to the manufacturer, this antibody is speci c for equine transferrin. e secondary antibody was horseradish peroxidase-conjugated donkey anti-sheep IgG (H+L) m at a dilution of 1:100,000.
Statistical Analysis. A er 21 days in the exposure environment, three heaves-a ected horses had not reached a clinical score of ≥ 10 with a ΔP Lmax of ≥ 15 cmH 2 O. ese horses were not included in the rest of this study and comparisons were performed with two groups of horses: controls (baseline n = 8, exposure n = 6) and heaves-a ected (baseline and exposure n = 5). Statistical analysis was performed with commercial so ware. p All data were tested for normality with the Shapiro-Wilk W test; most of the data were not normally distributed. e Kruskal-Wallis ANOVA was used to assess for a change over the three baseline measurements within each group (control and heavesa ected horses). e variables of interest (clinical score, PFT, BAL) did not show changes over the three baseline measurements therefore, measurements from each horse were averaged, and the averaged values were used for comparison with the exposure measurements.
Because there is not a robust nonparametric test for evaluating changes due to disease, time, and their interaction, factorial ANOVA was used to compare the clinical score, PFT, and BAL variables between the control and heavesa ected horses at the baseline and exposure measurements. When a statistically signi cant di erence was detected with the ANOVA (p ≤ 0.05), Tukey's post-hoc test was used for pairwise comparisons.
e pairwise two-tailed t-test was used to evaluate the relative concentration di erence of a peak (peptide) between sample (control and heaves-a ected horses) groups. To control the false discovery rate (FDR), a peptide with a q-value of ≤ 0.1 and a fold change of ≥ 10 was considered as a peptide with signi cant concetnration di erence between two sample groups.
e Western blot baseline measurements were also evaluated for a change over time within each group (control and heaves-a ected horses) with the Kruskal-Wallis ANO-VA. Neither group showed a signi cant di erence over baseline time points, therefore baseline measurements were averaged for each horse, and the averaged values were used for comparison to the exposure measurements with the factorial ANOVA. e relationship between the density of the bands of secretoglobin and transferrin and the pulmonary function and BALF cytology variables were evaluated using the Spearman Rank correlation test. A p-value of ≤ 0.05 was considered signi cant. Data are presented as median [range].
Results

Animals.
e heaves-a ected horses were older (21 [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] years) than the controls (15.5 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] years; p = 0.028).
ere was no signi cant di erence in heights or weights between the groups.
Experimental exposure. e heaves-a ected horses responded to exposure within 3-7 days and showed a signicant increase in clinical score, compared to the control horses (Table 1) . A er the experimental exposure to hay, the heavesa ected horses showed evidence of airway obstruction characterized by increased ΔP Lmax and R L and decreased C dyn compared to baseline values and to controls (Table 1) .
Bronchoalveolar lavage. A er exposure, the percentage of neutrophils signi cantly increased in both groups compared to baseline but the heaves-a ected horses had a signi cantly higher percentage of neutrophils in BALF than the controls (Table 1) .
Protein identi cation. A total of 2049 chromatographic peaks (peptides) were found in the LC-MS data; of which 370 peptides were identi ed for a total of 250 unique proteins with high con dence (Additional File 2). Only 43 of these proteins have been identi ed in the horse previously [6] . Of the 370 identi ed peptides, 33 were di erentially exBaseline Exposure
Control, n = 8
Heaves-a ected, n = 5 Control, n = 6
Heaves-a ected, ΔP Lmax = maximum change in transpulmonary pressure; C dyn = dynamic lung compliance; R L = total lung resistance pressed with 10 over-expressed in the heaves-a ected horses and 23 over-expressed in the control horses (Table 2) . Five peptides were identi ed from secretoglobin precursor, covering 33% of the protein, including one peptide only present in the precursor protein (peptide KSPLCA, Additional File 3). ese peptides did not display di erential expression between the heaves-a ected and control horses. Fourteen peptides from transferrin precursor protein were identi ed, covering 24.5% of the protein (Additional File 4) ; one peptide was absent in the control horses (p = 0.0094) and one peptide was absent in heaves-a ected horses (p = 0.012).
Western blot. Secretoglobin band density was not signi cantly di erent between the heaves-a ected and control horses at any time point (Figure 1 ). ere was a trend for secretoglobin band density during exposure to be lower than at baseline (p = 0.067). Transferrin band density was signicantly lower in heaves-a ected horses at exposure than control horses at baseline (Figure 2 ; p = 0.01). Secretoglobin band density was negatively correlated with BALF total nucleated (r = -0.37, p = 0.0084) and neutrophil (r = -0.40, p = 0.0048) cell counts and positively correlated with the percent of macrophages (r = 0.41, p = 0.0039; Additional File 5). Transferrin band density was inversely correlated with BALF neutrophil cell count (r = -0.32, p = 0.024) and positively associated with eosinophilic cell count (r = 0.32, p = 0.023; Additional File 5).
Discussion
e primary nding of this study was the identi cation of 190 peptides in BALF that were di erentially expressed between control and heaves-a ected horses a er induction of the disease by exposure to moldy hay. is disease model is commonly used to study the pathophysiology of heaves. e three horses that did not respond to the environmental challenge within 21 days in this study had been previously diagnosed with heaves in our laboratory, and had previously responded to a moldy hay challenge. It is possible that these horses were not sensitive to the allergens present in the di erent batch of moldy hay used in this study. Alternatively, the horses may have shown clinical signs if the exposure trial had continued longer although, most studies report successful exacerbation of heaves a er 1-14 days of exposure to moldy hay [16] [17] [18] [19] .
Results from this study may have been confounded by factors such as age, gender, and breed di erences between groups. Horses older than 7 years old are 6.6 times more likely to develop heaves than horses less than 4 years old but this likelihood does not change with increasing age. Horses 7 -10 years of age have a similar likelihood of developing heaves as horses 10-15 years of age or horses older than 15 years of age [15] . erefore, the di erences in protein expression in BALF between diseases and control horses are unlikely to be explained by the age di erence between the control horses (15.1 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] years) and the heaves-a ected horses (21 [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] years). Genders were not evenly distributed between groups, however, the risk of heaves is not signicantly di erent between female and castrated horses as compared to intact males [15] . ree of the six breeds represented in the study horses were present in both heaves and control groups, however, two other breeds with an identi ed risk of heaves ( oroughbred and Standardbred; [15] ) were only represented in the control group. is imbalance may have partially in uenced the di erential expression of proteins in BALF. Future studies will be needed to tease out the in uence of horse signalment (e.g. age, gender, and breed) on di erential expression of BALF proteins in horses with heaves.
Lung mechanics measurements at baseline con rmed that none of the horses had detectable airway obstruction with this test, although one heaves-a ected horse did have airway neutrophilia. A er experimental exposure, as expected, heaves-a ected horses showed signi cant airway obstruction while the control horses did not. Both groups of horses showed evidence of airway in ammation in BALF a er the experimental exposure, with a greater increase of neutrophil percentage in the heaves-a ected horses. Although the control horses showed no evidence of clinical signs of pulmonary disease and no airway obstruction, these Uncharacterized protein KIAA0195-like horses did develop pulmonary in ammation due to the experimental exposure, as reported in previous studies [20] [21] [22] . e proteome of BALF in healthy horses has previously been reported [6] . Although both the current study and previous report used nanospray ionization, the equipment, sample preparation, and MS techniques di ered between the studies. Both studies also used di erent so ware for protein identi cation, but the same database (NCBI) was utilized for identi cations. Our study identi ed 250 unique proteins based on tandem MS performed on BALF from two animals, whereas the other study identi ed 582 unique proteins based on tandem MS performed on two samples of pooled BALF (3 horses in each pool). Forty-three proteins were identi ed in both studies, including secretoglobin and transferrin. Further, this study was the rst to use proteomic techniques to compare protein concentrations between groups of healthy and heaves-a ected horses. We were able to nd 190 peptides and identify the parent proteins for 33 peptides that are di erentially expressed between heavesa ected and control horses. Secretoglobin and transferrin were chosen for validation in this study because previous research has implicated these proteins in in ammatory airway disease in horses and humans [14, [23] [24] [25] [26] [27] [28] [29] [30] . ese proteins were also selected because equine-speci c reagents are available for both secretoglobin and transferrin, whereas equine-speci c reagents are not available for many of the other proteins we identi ed in this experiment.
e lack of signi cant di erence in BALF secretoglobin expression in both the proteomics data and the Western blot data between heaves-a ected and control horses a er experimental exposure was surprising, as a study from another laboratory found lower secretoglobin expression in heaves-a ected horses compared to control horses, both while the heaves-a ected horses were in remission from disease and a er an experimental exposure trial [14] . Secretoglobin mRNA expression was also found to be downregulated in horses with summer pasture-associated heaves [23] . Although there was no statistical di erence (p = 0.067), we did see a tendency for secretoglobin expression to decrease with exposure, both in the heaves-a ected and control horses. e same Western blot reagents were used to detect equine secretoglobin in this study as in the study by Katavolos et al [14] , so the di erences in the results are likely due to factors outside the assay. e horses were exposed for a similar length of time in both studies. Based on comparison of airway neutrophilia, it appears that the experimental exposure trial reported here, while su cient to induce clinical signs in ve heaves-a ected horses, did not elicit the same degree of pulmonary in ammation as was seen in the study by Katavolos et al. If the exposure had elicited a stronger pulmonary in ammatory response or been conducted for a longer period of time, we may have seen a statistically signi cant change in secretoglobin expression.
ere was a large amount of individual variation in secretoglobin expression, particularly at the exposure measurement. A power calculation showed that a minimum of 15 horses per group 
Table 2 (Continuation).
Identi ed bronchoalveolar lavage uid proteins that were di erentially expressed (q-value ≤ 0.1 and fold change ≥ 10) between heaves-a ected and healthy control horses a er a hay exposure trial. A positive fold change indicates over-expression in control horses; a negative fold change indicates over-expression in heaves-a ected horses. Bold text indicates proteins previously identi ed in equine BALF. (6) would have been needed in order to achieve statistical signi cance between baseline and exposure secretoglobin levels (Type I error rate = 0.05 and power = 0.80). Asthmatic people and heaves-a ected horses have a lower percentage of secretoglobin positive airway epithelium cells, visualized with immunohistochemistry, compared to controls [14, 26] . A recent study in heaves-a ected horses showed that BALF neutrophils have higher intracellular concentrations of secretoglobin than BALF neutrophils from control horses, and this di erence is magni ed during exacerbation of clinical signs [27] . e same study also demonstrated that secretoglobin causes a decrease in oxidative burst in peripheral neutrophils of healthy horses, while also causing an increase in phagocytosis capacity. Secretoglobin exerts anti-in ammatory e ects by inactivating phospholipase A2, decreasing pro-in ammatory cytokine production, and altering phagocyte function, and may also attenuate the in ammatory response to endotoxin [28] . e reason for marked airway in ammation in heaves-a ected horses during exacerbation despite increased levels of secretoglobin within neutrophils is unclear, but it may be because secretoglobin production by airway epithelium is exhausted and insu cient to keep up with demand, or that secretoglobin e ects on neutrophils in horses with heaves are impaired.
Transferrin expression was signi cantly higher in the control horses at baseline than in the heaves-a ected horses at exposure, and the tendency was for transferrin to decrease with exposure. Again, the pulmonary in ammation seen in the control horses upon hay exposure in this study may have caused decreased transferrin expression, resulting in a lack of statistical di erence in transferrin expression between heaves-a ected horses and controls. It is also possible that a longer exposure trial, or a more severe exposure, may have resulted in a stronger pulmonary in ammatory response, and a signi cant di erence in transferrin expression between heaves-a ected and control horses. Transferrin expression also showed a large amount of individual variation and power calculation showed that a minimum of 7 horses per group would have been needed in order to achieve statistical signi cance between the secretoglobin levels in control and heaves-a ected horses a er exposure to hay (Type I error rate = 0.05 and power = 0.80).
In humans with cystic brosis, no signi cant di erence in BALF transferrin concentrations between a ected patients and healthy controls has been reported [29] . BALF transferrin was also evaluated in healthy people a er exposure to swine dust in a con nement operation for three hours. Within 24 hours from the start of exposure to swine dust, BALF transferrin concentrations increased by 2.6 fold.
e change in transferrin concentration was correlated with the total dust exposure levels [30] . e trend for a decrease in BALF transferrin expression in heaves-a ected horses a er the experimental exposure trial seems to be in contrast to this study. In the study presented here, samples were not taken from the heaves-a ected horses in the experimental exposure until their clinical signs and lung function reached a certain level of severity. It is possible that if these horses had been tested earlier in the course of disease (more acute in ammation) or later in the exposure (chronic in ammation), transferrin expression may have been di erent.
We also found that secretoglobin and transferrin expression were stable over time in heaves-a ected horses that were in clinical remission from the disease and in healthy controls. e stability of BALF secretoglobin and transferrin may make these proteins potential targets for monitoring subclinical in ammation, or response to environmental changes.
We performed proteomics on cell-free BALF supernatant at one time point a er experimental exposure. Di erent protein expression levels may have been obtained by evaluating the cellular fractions of BALF rather than the cellfree supernatant, as secretoglobin has been found to be concentrated in BALF neutrophils in horses [27] . In addition, if repeated measurements had been performed during the exposure trial, we would have been able to track the changes in secretoglobin and transferrin secretion. As clinical signs of heaves tend to worsen with prolonged environmental exposure, it is likely that we would have found altered expression patterns for both secretoglobin and transferrin over time.
Concluding Remarks
In this study, we demonstrated that proteomic techniques can be used for discovery of proteins in BALF of horses with heaves. Two proteins identi ed using mass spectrometry were con rmed using Western blot. Many additional proteins identi ed with proteomics show di erential expression between the control and heavesa ected horses. Since only one pulmonary disease was evaluated in this study, it is likely that just a fraction of the di erentially expressed proteins identi ed here are speci c biomarkers for heaves and that some of the di erentially expressed proteins may be non-speci c indicators of pulmonary in ammation (e.g., immunoglobulins). Further validation, including con rmation of the proteins' identity using techniques such as Western blot, and investigation of protein expression in other pulmonary diseases must occur before a protein can be considered a biomarker for heaves. 
